ARG30308
Immature B Cell Marker Antibody Panel (CD19, CD20, CD22, IgM Fc) (FACS)
Publication1
Component
| Cat No | Component Name | Host clonality | Reactivity | Application | Package |
|---|---|---|---|---|---|
| ARG23128 | anti-CD19 antibody [LE-CD19] | Mouse mAb | Hu | ELISA, FACS, IP, IHC-P, WB | 50 μg |
| ARG62775 | anti-CD22 antibody [MEM-01] | Mouse mAb | Hu, NHuPrm | FACS, IP, WB | 50 μg |
| ARG62767 | anti-CD20 antibody [MEM-97] | Mouse mAb | Hu, Bov, Pig | FACS, IP | 50 μg |
| ARG63040 | Mouse anti-Human IgM (Fc) antibody [CH2] | Mouse mAb | Hu | ELISA, FACS, ICC/IF, WB | 50 μg |
| ARG65350 | Goat anti-Mouse IgG antibody (HRP) | Goat pAb | Ms | ELISA, IHC-P, WB | 50 μl |
| ARG65351 | Goat anti-Rabbit IgG antibody (HRP) | Goat pAb | Rb | ELISA, IHC-P, WB | 50 μl |
Overview
| Product Description | B cell development occurs in the bone marrow and peripheral lymphoid tissues such as spleen. In the bone marrow, pro B Cell, pre B Cell and Immature B Cell develop. During this differentiation, several stages of rearrangement occur at immunoglobulin locus, resulting in the generation and surface expression of different types of receptors, such as pre-B-cell receptor. Different markers are also expressed at the surface of these cells throughout the development of B cell. Immature B Cells express IgM, CD19, CD20 and CD22 on the surface of the cells. Arigo has these marker antibodies in the application of Flow Cytometry for the convenience of identifying Immature B Cells in B cell populations. Cambier et al. Nature Rev Immunology 7: 633-643 (2007) Alberts et al. Molecular Biology of the Cell: 1367 Parham. The Immune System |
|---|---|
| Target Name | Immature B Cell Marker |
| Alternate Names | Immature B Cell Marker antibody; CD19 antibody; CD20 antibody; CD22 antibody |
Properties
| Storage Instruction | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
|---|---|
| Note | For laboratory research only, not for drug, diagnostic or other use. |
Specific References
KDF1 Promoted Proliferation, Migration and Invasion of Lung Adenocarcinoma Cells through Activating STAT3 and AKT Pathway
ARG65350: WB /
